Coronary Stents Market Overview:
As per MRFR analysis, the Coronary Stents Market Size was estimated at 6.43 (USD Billion) in 2023. The Coronary Stents Market Industry is expected to grow from 6.62(USD Billion) in 2024 to 9.2 (USD Billion) by 2035. The Coronary Stents Market CAGR (growth rate) is expected to be around 3.04% during the forecast period (2025 - 2035).
Key Coronary Stents Market Trends Highlighted
The Global Coronary Stents Market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases, which has become a leading cause of mortality worldwide. This rise can be attributed to lifestyle changes, such as poor dietary habits and reduced physical activity, contributing to a higher incidence of heart-related issues. Additionally, advances in technology have led to the development of drug-eluting stents, which offer improved outcomes for patients by reducing the risk of restenosis. As these devices become more widely accepted, healthcare providers are increasingly opting for these advanced treatment modalities, propelling market expansion.
Particularly in regions with developing healthcare infrastructures, there are numerous opportunities to be investigated in the global market. For example, the adoption of coronary stents in emerging markets can be facilitated by the growing awareness of cardiovascular health and the increased investments in healthcare. Furthermore, regulatory initiatives that are designed to enhance healthcare accessibility and increase funding for cardiovascular research create an attractive environment for the development of innovative products and the emergence of new market entrants. A shift toward minimally invasive procedures, which are perceived as less traumatic for patients and frequently lead to quicker recovery times, is also evident in recent trends in the Global Coronary Stents Market.
The increasing prevalence of coronary stenting procedures in a variety of healthcare facilities indicates a growing level of trust in these devices. Additionally, there is a greater emphasis on patient-centric treatment approaches, which has motivated manufacturers to develop stents that prioritize patient convenience in addition to meeting functional requirements. Consequently, technological advancements and changes in consumer preferences continue to influence the market, resulting in its ongoing evolution.
  Â
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Stents Market Drivers
Increasing Prevalence of Cardiovascular Diseases
The Global Coronary Stents Market Industry is significantly driven by the increasing prevalence of cardiovascular diseases (CVDs), which are a leading cause of mortality worldwide. According to the World Health Organization, cardiovascular diseases claim approximately 17.9 million lives annually, accounting for 32 percent of all global deaths. This alarming statistic stresses the urgent need for effective treatment options, such as coronary stents, to improve patient outcomes.
Regions like North America and Europe have shown a rising trend in CVD cases due to lifestyle factors, thereby escalating the demand for innovative interventions in the form of stents. Additionally, vital organizations, including the American Heart Association, continue to report incremental growth in heart-related health issues, supporting the necessity for continuous advancements and investments in the Global Coronary Stents Market Industry as they seek to enhance treatment efficacy and reduce readmission rates.
Technological Advancements in Stent Design
Technological advancements in stent design and materials are another critical driver for the Global Coronary Stents Market Industry. The introduction of drug-eluting stents, which release medication to prevent blood vessel blockages, has already revolutionized treatment methods. A study published by the European Society of Cardiology highlights a reduction in restenosis rates by up to 30 percent with the use of these advanced stents, compared to bare-metal options.
Furthermore, ongoing Research and Development efforts by key players such as Boston Scientific and Abbott are expected to lead to further innovations, including bioresorbable stents, which promote healing and are absorbed by the body over time. The growth in these technologies indicates a promising future for the Global Coronary Stents Market Industry as the demand for safer and more effective treatment options continues to rise.
Aging Population and Lifestyle Changes
The aging global population and changing lifestyle habits are significantly influencing the growth of the Global Coronary Stents Market Industry. As per the United Nations, the number of people aged 60 years or over is projected to reach 2.1 billion by 2050, which correlates with an increased incidence of cardiovascular issues. Additionally, lifestyle changes such as unhealthy diets, sedentary habits, and increased stress levels contribute to the rising incidence of heart diseases among younger individuals as well.
Governmental health initiatives worldwide are increasingly focusing on promoting awareness and preventive measures against heart diseases, leading to a larger patient base requiring stenting procedures. Established organizations, including the World Health Organization, are working on global programs to tackle lifestyle-related health issues, thereby indirectly boosting the demand for effective stenting solutions in the Global Coronary Stents Market Industry.
Coronary Stents Market Segment Insights:
Coronary Stents Market Type Insights
The Global Coronary Stents Market segment classified by Type showcases a significant evolution in interventional cardiology, with distinct categories shaping the market landscape. In 2024, the overall market is projected to be valued at 6.62 USD Billion, reflecting a comprehensive growth trajectory driven by advancements in stent technology and increasing cardiovascular diseases globally.
The Drug-Eluting Stents segment commands a notable share of the market, valued at 2.88 USD Billion in 2024 and anticipated to grow to 4.0 USD Billion by 2035, highlighting its dominance due to its ability to reduce restenosis rates significantly and improve patient outcomes.
This significant market holding is largely attributed to the increasing adoption of these stents owing to their effective drug delivery mechanism that inhibits cell proliferation. On the other hand, Bare-Metal Stents are valued at 2.34 USD Billion in 2024 and are expected to reach 3.2 USD Billion by 2035.
Although they offer a cost-effective solution for specific patient demographics, the rise of Drug-Eluting Stents has overshadowed their growth potential, making them a less preferred option in today's clinical practice.
Furthermore, the Bioabsorbable Stents market stands at 1.4 USD Billion in 2024 and is expected to grow to 2.0 USD Billion by 2035, representing an emerging technology with the potential to offer biocompatibility advantages by gradually dissolving post-artery healing.
Each segment plays a crucial role in addressing various patient needs, with Drug-Eluting Stents leading the charge in revenue generation and innovation, while Bare-Metal and Bioabsorbable Stents cater to niche markets and specific clinical indications.
This market segmentation not only showcases the diversity within the Global Coronary Stents Market but also highlights the importance of ongoing innovation and the need for personalized patient care in managing coronary artery disease effectively. Overall, the growth in these segments signifies a robust market landscape driven by advancements in technology and an increasing emphasis on improved patient outcomes.
  Â
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Stents Market Material Insights
The Global Coronary Stents Market, specifically focusing on the Material segment, has shown significant value with an expected valuation of 6.62 USD Billion in 2024. The market is characterized by a diversified approach toward materials used in stents, primarily comprising Metal Stents, Polymer Stents, and Coated Stents. Metal Stents continue to dominate the market due to their long-standing reliability and mechanical strength, making them a preferred choice in numerous procedures.
Conversely, Polymer Stents have been gaining traction, particularly with advancements in biocompatible materials that enhance patient outcomes and safety.Coated Stents also play a critical role, offering drug-eluting capabilities that reduce the chances of restenosis, thereby improving long-term efficacy.
The Global Coronary Stents Market data reflects a steady growth trajectory driven by an aging population, increasing prevalence of cardiovascular diseases, and ongoing innovations in stent technology. Additionally, market statistics point toward a rising demand for minimally invasive procedures, creating substantial opportunities for the different material types within the market. These trends underscore the importance of various material attributes in catering to diverse patient needs and enhancing procedural success rates.
Coronary Stents Market End Use Insights
The Global Coronary Stents Market is projected to reach a valuation of 6.62 USD Billion in 2024, with significant contributions coming from the End Use segment, which includes Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Labs.
Hospitals play a crucial role as they often have advanced facilities and experienced surgical teams, fostering a higher volume of procedures. Ambulatory Surgical Centers have emerged as significant due to their cost-effectiveness and efficiency, providing outpatient services that cater to a growing patient demographic seeking timely interventions.
Cardiac Catheterization Labs, being specialized units within hospitals, further highlight the importance of advanced technology and precision in stenting procedures, resulting in efficient patient care. The trends in the Global Coronary Stents Market show growing investment in these facilities, driven by an increase in cardiovascular diseases and the aging population.
This sector faces challenges such as regulatory hurdles and the need for continuous innovation. However, the ongoing demand for minimally invasive procedures presents numerous opportunities for growth, ensuring that the End Use segment remains a focal point of market research and development initiatives in the years to come.
Coronary Stents Market Application Insights
The Global Coronary Stents Market revenue reached 6.62 USD Billion in 2024, showcasing notable growth potential within the Application segment. This segment encompasses critical areas such as Coronary Artery Disease, Peripheral Artery Disease, and Acute Myocardial Infarction, each reflecting unique challenges and opportunities. Coronary Artery Disease, being the most prevalent, significantly influences the demand for coronary stents due to an increasing global incidence driven by lifestyle factors and aging populations.
Peripheral Artery Disease also plays a crucial role, as it affects a considerable portion of the population, leading to a rising need for effective stenting solutions.Acute Myocardial Infarction showcases the urgent necessity for timely intervention, where stents are vital for restoring blood flow and enhancing patient outcomes.
Overall, the Global Coronary Stents Market is poised for growth as advancements in stent technology enhance treatment effectiveness, addressing major healthcare concerns for these key applications. Market growth is supported by increasing awareness about cardiovascular diseases and improved access to healthcare services worldwide.
Coronary Stents Market Regional Insights
The Global Coronary Stents Market exhibits notable regional differentiation in its performance and potential growth, with North America taking the lead with a market valuation of 2.45 USD Billion in 2024, expected to increase to 3.15 USD Billion by 2035, reflecting its majority holding in the industry. The region benefits from advanced healthcare infrastructure and significant investment in Research and Development, which drives innovation in coronary stent technologies.
Europe follows with a valuation of 1.8 USD Billion in 2024 and is projected to reach 2.28 USD Billion by 2035, supported by a robust regulatory framework and a rising prevalence of cardiovascular diseases.The Asia-Pacific (APAC) region is crucial as well, with a projected value of 2.0 USD Billion in 2024 and a rise to 2.65 USD Billion by 2035, attributed to its large population and growing awareness of cardiac conditions.
Meanwhile, South America shows potential for expansion with a value of 0.25 USD Billion in 2024, reaching 0.33 USD Billion by 2035; however, its current market size emphasizes the challenges posed by healthcare access and economic disparities. The Middle East and Africa (MEA) region, while smaller at 0.12 USD Billion in 2024 and projected at 0.18 USD Billion in 2035, still presents opportunities for growth driven by an increasing focus on improving healthcare systems and addressing cardiovascular health.These regional dynamics paint a comprehensive picture of the Global Coronary Stents Market landscape, revealing both opportunities and challenges inherent in catering to diverse healthcare needs across different regions.
  Â
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Stents Market Key Players and Competitive Insights:
The Global Coronary Stents Market has witnessed significant growth in recent years due to the rising prevalence of cardiovascular diseases, increasing geriatric population, and advancements in stent technology. As a result, an array of companies have entered the market, leading to intense competition driven by technological innovation, product differentiation, and strategic collaborations.
Manufacturers are not only focusing on expanding their product portfolios but are also seeking to enhance their operational efficiencies to capture a larger market share. The competitive landscape is characterized by the presence of both established players and emerging companies, all vying to meet the diverse needs of healthcare providers and patients globally.
Factors such as regulatory approvals, patient safety regulations, and reimbursement policies are also influencing market dynamics as firms aim to comply while maintaining a competitive edge.MicroPort has positioned itself as a strong player within the Global Coronary Stents Market, leveraging its innovative range of products and robust research and development capabilities.
The company's commitment to quality and technological advancement has resulted in the development of stent systems that cater to varying patient needs, enhancing effectiveness and safety. MicroPort has been proactive in expanding its international footprint through partnerships and collaborations, which has significantly improved its market presence. The company's superior manufacturing processes and dedication to continuous improvement enable it to provide high-quality solutions in the coronary stenting domain.
Its strengths lie in its ability to quickly adapt to market demands and respond efficiently to emerging healthcare challenges, thereby solidifying its reputation among healthcare professionals and patients alike.Philips is recognized as a leading player in the Global Coronary Stents Market, focusing on developing innovative solutions aimed at improving clinical outcomes and patient care.
The company emphasizes the integration of advanced technologies, such as imaging and data analytics, to optimize its product offerings in stenting. Philips offers a range of key products, including drug-eluting stents and bioresorbable stents, which are designed to meet the diverse needs of cardiologists around the world.
The company's strong presence in emerging markets, aided by strategic mergers and acquisitions, has enhanced its portfolio and provided it with competitive advantages. Philips is dedicated to research and development, constantly working on improving existing products and launching new ones to address current healthcare challenges.
By leveraging its expertise in patient monitoring and training, Philips is not only focused on delivering cutting-edge stent solutions but is also committed to enhancing the overall quality of care in the cardiovascular field globally.
Key Companies in the Coronary Stents Market Include:
- Apex Medical Technologies
- Sahajanand Medical Technologies
Coronary Stents Market Industry Developments
The Global Coronary Stents Market has witnessed notable developments recently, particularly with the growing demand for advanced medical devices owing to the rise in cardiovascular diseases. Companies like Abbott and Boston Scientific continue to innovate, enhancing stent technologies for better patient outcomes. In terms of mergers and acquisitions, MicroPort announced a significant acquisition in March 2023, targeting a key competitor to expand its market presence.
Johnson and Johnson is also in discussions to acquire an emerging Stent technology firm to bolster their portfolio, which could shift market dynamics. The past two years have seen B.Braun launch new bioresorbable stent systems in December 2022, marking a breakthrough in minimally invasive treatments. Terumo has also been enhancing its Research and Development capabilities to accelerate product introductions.
Furthermore, the overall market valuation for coronary stents has surged, driven by increasing investments in the healthcare sector and enhanced patient access to advanced therapies. Reports indicate that the global coronary stents market is projected to grow substantially, reinforcing the significance of continuous innovation and strategic partnerships among leading companies like Medtronic and Cardinal Health to capture emerging opportunities.
Coronary Stents Market Segmentation Insights
Coronary Stents Market Type Outlook
Coronary Stents Market Material Outlook
Coronary Stents Market End Use Outlook
- Ambulatory Surgical Centers
- Cardiac Catheterization Labs
Coronary Stents Market Application Outlook
- Peripheral Artery Disease
- Acute Myocardial Infarction
Coronary Stents Market Regional Outlook
| Report Attribute/Metric Source: |
Details |
| MARKET SIZE 2023 |
6.43(USD Billion) |
| MARKET SIZE 2024 |
6.62(USD Billion) |
| MARKET SIZE 2035 |
9.2(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) |
3.04% (2025 - 2035) |
| REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR |
2024 |
| MARKET FORECAST PERIOD |
2025 - 2035 |
| HISTORICAL DATA |
2019 - 2024 |
| MARKET FORECAST UNITS |
USD Billion |
| KEY COMPANIES PROFILED |
MicroPort, Philips, Johnson and Johnson, Terumo, B.Braun, Abbott, ERBE Elektromedizin, Meril Life Sciences, Kimal plc, Apex Medical Technologies, Medtronic, Stentys, Sahajanand Medical Technologies, Cardinal Health, Boston Scientific |
| SEGMENTS COVERED |
Type, Material, End Use, Application, Regional |
| KEY MARKET OPPORTUNITIES |
Growing aging population demand, Technological advancements in stent design, Increasing prevalence of cardiovascular diseases, Rising healthcare expenditure globally, Expansion in emerging markets |
| KEY MARKET DYNAMICS |
Technological advancements, Increasing cardiovascular diseases, Growing geriatric population, Rising healthcare expenditure, Strong regulatory support |
| COUNTRIES COVERED |
North America, Europe, APAC, South America, MEA |
Coronary Stents Market Highlights:
Frequently Asked Questions (FAQ) :
The Global Coronary Stents Market is projected to be valued at 6.62 billion USD in 2024.
By 2035, the Global Coronary Stents Market is expected to reach a value of 9.2 billion USD.
The expected CAGR for the Global Coronary Stents Market from 2025 to 2035 is 3.04%.
North America will hold the largest market share in 2024, valued at 2.45 billion USD.
In 2035, the Coronary Stents Market in Europe is projected to be valued at 2.28 billion USD.
Major players include MicroPort, Philips, Johnson & Johnson, Terumo, B.Braun, Abbott, Medtronic, and Boston Scientific among others.
The market value of Drug-Eluting Stents is 2.88 billion USD in 2024.
Bare-Metal Stents are expected to be valued at 3.2 billion USD in 2035.
Opportunities exist due to technological advancements in stent design and increased prevalence of cardiovascular diseases globally.
Potential challenges include stringent regulatory frameworks and high costs associated with advanced stent technologies.
